Dr Mary Sommerlad, a consultant dermatologist and spokesperson for the British Skin Foundation told Sun Health: "The male beard area is heavily ... condition called alopecia areata," she said.

According to the American Academy of Dermatology, Alopecia areata is a disease that causes hair loss. Most people lose hair on their scalp or beard area, but hair loss can occur anywhere on your body.

Kristen Whitney, DO, FAAD, determines systemic treatment options for severe alopecia areata based on the patient’s medical history, past treatments tried, potential adverse events, in addition ...

The National Institutes of Health body explained that "Alopecia areata typically begins with sudden loss of round or oval patches of hair on the scalp." However, the beard area in men, or the eyebrows ...

A remarkable Bay Area girl is on a mission to reduce the ... At 8 years old, Brynn was diagnosed with alopecia areata — a mysterious autoimmune condition that causes people to lose some or ...

Alopecia areata is a classic example of this. This condition occurs when the immune system targets hair follicles, leading to patchy bald spots, typically on the scalp, but sometimes affecting ...

It can come in a variety of forms, including one of the most commonly known as alopecia areata. Famous women who live with alopecia include Jada Pinkett Smith and “Summer House: Martha’s ...

Alopecia areata is an autoimmune disease, where the body's immune system attacks the follicles of the hair, causing it to fall out. Alopecia is more than just hair loss Toby Penty on alopecia ...

Earlier this year a new drug to treat severe alopecia - an autoimmune condition that causes hair loss - was given the green light for NHS use. Some are keen to try it, others aren't - and some ...

Arash Mostaghimi, MD, MPA, MPH, assistant professor of dermatology, director of the inpatient dermatology consult service, and codirector of the Complex Medical Dermatology Fellowship at Brigham & ...

Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...